Your email has been successfully added to our mailing list.

×
-0.00220264317180612 -0.00110132158590306 0 0.00220264317180612 0.00440528634361244 -0.0209251101321585 -0.0121145374449339 -0.0286343612334802
Stock impact report

Achillion's Recent Positive Data Points To A Major Inflection Point Moving Forward [Seeking Alpha]

ACHISON INC A (ACHN) 
Last achison inc a earnings: 11/7 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achillion.com/investor-relations
Company Research Source: Seeking Alpha
Achillion's Recent Positive Data Points To A Major Inflection Point Moving Forward Summary Achillion Pharmaceuticals reports positive data from a phase 1 study using ACH-5228 as a treatment for complement mediated diseases. ACH-5228 is a second-generation Factor D inhibitor to treat complement mediated diseases, with biggest focus of the company being on its first-generation product ACH-4471 being tested in multiple mid-stage studies. Data from a phase 2 study using ACH-4471 plus eculizumab to treat suboptimal PNH responders to eculizumab is expected to be released by Q4 of 2019. Achillion has a diversified pipeline with multiple Factor D inhibitors to target the complement pathway, but several competitors such as Alexion, Ra, and Apellis should be monitored closely. ACHN reported positive data from a phase 1 study Source: Preliminary Data Offers Investors A Lot Of Optimism The big reason for the rise in stock price last week was the positive data from the phase 1 multiple ascending d Show less Read more
Impact Snapshot
Event Time:
ACHN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ACHN alerts
Opt-in for
ACHN alerts

from News Quantified
Opt-in for
ACHN alerts

from News Quantified